Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedIsrael study site list updated: Tel Litwinsky added as a study location and Qiryat Krinitzi removed. This changes the enrollment options for participants in Israel.SummaryDifference0.1%

- Check11 days agoChange DetectedTel Litwinsky, Israel was removed and Qiryat Krinitzi, Israel was added as recruitment sites, updating the study's Israel-based site network. This change reflects a shift in the participating centers within the country.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a new version of the page template. This reflects a maintenance/update to the page infrastructure rather than substantive content changes.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAn added revision entry shows the current version as v3.6.5 and the previous version v3.6.4 is removed from the history. This update reflects a new baseline in the revision log.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3, indicating an updated site build while leaving study data and user-facing features unchanged.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, updating the page's version metadata. This change does not modify the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.